Concepedia

Markus Albers

MA

6

Publications

138

Citations

6

H-Index

1986

Active since

Affiliations

Bayer (Germany)(Current)

Markus Albers is an author at Bayer (Germany) specializing in medicine, drug discovery, and pharmacotherapy.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyMolecular PharmacologyBiochemistryAllergyUrologyChemistryImmunology

Publications per year

1986–2007

6

Publications

6

Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4

Hiromi Okigami, Keisuke Takeshita, Masaomi Tajimi et al. · European Journal of Pharmacology · 2006 · 42 citations

Allergy, Immunodeficiencies, Immunology +8

Biphenyls as potent vitronectin receptor antagonists

Klaus Urbahns, Michael Härter, Markus Albers et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 25 citations · Full text

Functional Selectivity, Medicine, Pharmacotherapy +2

Cluster complexes containing opened transition metal polyhedra

Markus Albers · Coordination Chemistry Reviews · 1986 · 20 citations

Materials Science, Inorganic Chemistry, Transition Metal Polyhedra +6

Biphenyls as potent vitronectin receptor antagonists. Part 2: biphenylalanine ureas

Klaus Urbahns, Michael Härter, Andrea Vaupel et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 20 citations · Full text

Molecular Pharmacology, Urology, Functional Selectivity +6

Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides

Klaus Urbahns, Michael Härter, Markus Albers et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 17 citations · Full text

Molecular Pharmacology, Pharmaceutical Science, Biochemistry +9

Rows per page

1–5 of 6